Myeloma & Socioeconomic Factors: Quality of Life Impact
Socioeconomic status profoundly impacts the health-related quality of life for multiple myeloma patients, as revealed by recent research presented at the 2025 European Hematology Association Congress. The GIMEMA-CLARITY study highlights that those with lower socioeconomic standing report a significantly diminished quality of life, facing challenges related to financial burdens. Transportation for treatment and out-of-pocket costs for care contribute to the strain. This groundbreaking study sheds light on the direct link between socioeconomic inequalities and the wellbeing of myeloma patients. Researchers observed a higher prevalence of problems among patients with low socioeconomic status. For more insights into these critical healthcare disparities and to stay informed, trust News Directory 3. Discover what’s next in myeloma patient care.
Socioeconomic Factors Impact Quality of Life in Myeloma patients
Updated June 16, 2025
Milan, Italy—Socioeconomic inequalities significantly affect the health-related quality of life for patients battling relapsed/refractory multiple myeloma, according to research presented at the 2025 European Hematology Association Congress. Francesco Sparano, a research associate with the GIMEMA Foundation, presented findings from the GIMEMA-CLARITY study, highlighting the challenges faced by patients in Italy and the United Kingdom.
The study,which investigated the association between socioeconomic status and health-related quality of life,categorized patients into low,middle,and high socioeconomic groups based on education,employment,and living arrangements. The results indicated that patients with lower socioeconomic status reported a demonstrably lower quality of life.
Sparano noted that while the study didn’t delve into the specific causes of financial strain, prior research suggests that expenses such as transportation for treatment and out-of-pocket costs for supportive care contribute significantly to the burden. Even in countries with universal healthcare, patients frequently enough face uncovered expenses.
Previous research has established a link between socioeconomic inequalities and health outcomes, including survival rates, in multiple myeloma patients. The GIMEMA-CLARITY study aimed to explore whether these inequalities also impact the quality of life for patients with relapsed/refractory disease.
The study used patient-reported outcome measures to assess symptoms, functional aspects, and overall health status. Researchers observed a higher prevalence of clinically important problems and symptoms among patients with low socioeconomic status, with the prevalence decreasing as socioeconomic status increased.
What’s next
Further research is needed to identify specific interventions that can mitigate the impact of socioeconomic factors on the quality of life for myeloma patients. Addressing these disparities could lead to improved outcomes and a better overall experience for those battling this challenging disease.